OTC

Strength

2; 10; 5 mg/5mL; mg/5mL; mg/5mL

NDC

68047012916

Classification

Generic

Dosage Form

LIQUID

Route

ORAL

Last Updated

10/22/2025

Approval Type

OTC MONOGRAPH DRUG

FDA Application

M012

On Market Since

6/1/2012

Pharmacological Classes

Adrenergic alpha1-Agonists
Sigma-1 Agonist
Sigma-1 Receptor Agonists
Uncompetitive N-methyl-D-aspartate Receptor Antagonist
Uncompetitive NMDA Receptor Antagonists
alpha-1 Adrenergic Agonist

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

+0.2%

3Y

+5.5%

5Y

+5.5%

All

+0.1%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.